Small molecule, big potential for treating prostate cancer

Prostate cancer growth is often driven by male sex hormones called androgens. Hormone therapy is commonly administered to lower the level of androgens in the body, but relapse is common when the cancer cells develop resistance to these therapies.

Read the full article here. 

Source: Bendta Schroeder - MIT News